...
首页> 外文期刊>Toxicological sciences: An official journal of the Society of Toxicology >The use of rat lens explant cultures to study the mechanism of drug-induced cataractogenesis
【24h】

The use of rat lens explant cultures to study the mechanism of drug-induced cataractogenesis

机译:利用大鼠晶状体外植体培养物研究药物性白内障发生的机制

获取原文
获取原文并翻译 | 示例

摘要

Lens explant cultures were used to assess the mechanism of drug-induced cataractogenic potential of NVS001, a peroxisome proliferator-activated receptor delta (PPARδ) agonist, which resulted in cataract in all treated animals during a 13-week rat study. Ciglitazone, a PPARγ agonist and cataractogenic compound, was used as a positive control to validate this model. Rat lenses were extracted and cultured in medium supplemented with antibiotics for 24-h preincubation pretreatment. Lenses showing no signs of damage at the end of the preincubation pretreatment period were randomized into five experimental groups, (1) untreated control, (2) 0.1% dimethyl sulphoxide control, (3) 10μM NVS001, (4) 10μM ciglitazone, and (5) 10μM acetaminophen (negative control). Lenses were treated every 24 h after preincubation pretreatment for up to 48 h. Samples for viability, histology, and gene expression profiling were collected at 4, 24, and 48 h. There was a time-dependent increase in opacity, which correlated to a decrease in viability measured by adenosine triphosphate levels in NVS001 and ciglitazone-treated lenses compared with controls. NVS001 and ciglitazone had comparable cataractogenic effects after 48 h with histology showing rupture of the lens capsule, lens fiber degeneration, cortical lens vacuolation, and lens epithelial degeneration. Furthermore, no changes were seen when lenses were treated with acetaminophen. Gene expression analysis supported oxidative and osmotic stress, along with decreases in membrane and epithelial cell integrity as key factors in NVS001-induced cataracts. This study suggests that in vitro lens cultures can be used to assess cataractogenic potential of PPAR agonists and to study/understand the underlying molecular mechanism of cataractogenesis in rat.
机译:使用晶状体外植体培养物评估过氧化物酶体增殖物激活受体δ(PPARδ)激动剂NVS001的药物诱发白内障的潜在机制,在为期13周的大鼠研究中,所有被治疗的动物均导致白内障。西格列酮,一种PPARγ激动剂和白内障致病性化合物,被用作阳性对照来验证该模型。提取大鼠晶状体,并在补充抗生素的培养基中培养,以进行24小时预培养预处理。在预培养预处理阶段结束时无损伤迹象的镜片被随机分为五个实验组,(1)未经处理的对照,(2)0.1%二甲基亚砜对照,(3)10μMNVS001,(4)10μM西格列酮,和( 5)10μM对乙酰氨基酚(阴性对照)。预孵育预处理后每24小时处理一次镜片,最长48小时。在第4、24和48小时收集活力,组织学和基因表达谱的样品。与对照相比,在NVS001和西格列酮治疗的晶状体中,不透明度随时间的增加,这与通过三磷酸腺苷水平测量的生存能力降低有关。 NVS001和西格列酮在48 h后具有可比的致白内障作用,组织学显示晶状体囊破裂,晶状体纤维变性,皮质晶状体空泡和晶状体上皮变性。此外,当用对乙酰氨基酚处理镜片时,未见变化。基因表达分析支持氧化应激和渗透应激,以及膜和上皮细胞完整性的降低,这是NVS001引起的白内障的关键因素。这项研究表明,体外晶状体培养可用于评估PPAR激动剂的致白内障潜能,并研究/了解大鼠白内障发生的潜在分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号